Press

Follow our blog and stay up to date.

Why critical paths towards oncology innovation can traverse India – By Devang Mehta
ET Healthworld

Why critical paths towards oncology innovation can traverse India – By Devang Mehta

Anthill Ventures announces Indus X, India’s first Global Smart City Scaling Program
Business Standard

Anthill Ventures announces Indus X, India’s first Global Smart City Scaling Program

Anthill partners with Israeli health tech firm Kanfit3D for India market expansion
ANI News

Anthill partners with Israeli health tech firm Kanfit3D for India market expansion

Lumos Health Accelerator onboards startups in early cancer detection and advanced cancer prognostics
Business Standard

Lumos Health Accelerator onboards startups in early cancer detection and advanced cancer prognostics

Atmanirbhar Bharat: How healthtech startups can help Modi govt scale Covid vaccination drive across India By Devang Mehta, Partner, Anthill Ventures

Atmanirbhar Bharat: How healthtech startups can help Modi govt scale Covid vaccination drive across India By Devang Mehta, Partner, Anthill Ventures

SALUD, a lifestyle beverage brand raises the bar with its launch of the first ever Ready-To-Drink Gin & Tonic in India
APN News

SALUD, a lifestyle beverage brand raises the bar with its launch of the first ever Ready-To-Drink Gin & Tonic in India

YourStory speaks with Anthill partner, Devang Mehta

YourStory speaks with Anthill partner, Devang Mehta

Speakin Network interviews Anthill partner, Devang Mehta

Speakin Network interviews Anthill partner, Devang Mehta

Portfolio company SquadRun raises $5m from consortium led by Chiratae Ventures
VC Circle

Portfolio company SquadRun raises $5m from consortium led by Chiratae Ventures

Anthill weighs in with Venture Capital insights for HealthTech in Asia
Latoken VC

Anthill weighs in with Venture Capital insights for HealthTech in Asia

Anthill Partner Devang Mehta in a panel discussion on BioTech Investments
Latoken

Anthill Partner Devang Mehta in a panel discussion on BioTech Investments

Anthill and its Partners opine on Future Workplaces through IVCA Webinar

Anthill and its Partners opine on Future Workplaces through IVCA Webinar

Scroll to top